WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

POTENTIAL USE OF MUCIN AS BIOMARKER FOR THE DIAGNOSIS OF BREAST CANCER

Abdelfattah M. Attallah*, Mohamed El-Far, Mohamed M. Omran, Mohamed S. Elbendary, Karim S. Salama and Ibrahim El-Dosoky

ABSTRACT

Background and Aim: Breast cancer is considered the leading cause of cancer death among females in developing countries. Tumor markers are biochemical indicators for the presence of tumor. Aim of study to identify, quantity and evaluate of mucin-1 for diagnosis breast cancer. Methods: Sodium dodecyl sulfate-polyacrylamide gel electrophoresis, western blotting and enzyme linked immunosorbent assay (ELISA) were used for identifying mucin-1 in sera of women with breast cancer (n= 88) and healthy women (n= 32). Results: MUC1 was identified at 130 kDa. The mean level of serum mucin-1 in women with breast cancer was higher than (5.60 ± 0.68 μg/ml) in the healthy women (1.32 ± 0.16 μg/ml) with extremely high significant difference (p < 0.0001). There was significant correlation between age and Mucin-1 in women with breast cancer (r = 0.40; p <0.0001). MUC1 showed high diagnostic performance with area under receiver-operating characteristic curve (AUC = 0. 91), sensitivity 75.0%, specificity 93.8%, PPV 97.1% NPV 57.7% and efficiency 80.0 %. Conclusion: It was showed that MUC1 may help in diagnosis of breast cancer and can be used in follow up of treatment.

Keywords: Mucin, Breast Cancer, Blood markers, Diagnosis.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More